AMPH — Amphastar Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Amphastar Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	85.4	106	137	176	257
Net Total Accounts Receivable
Net Total Receivables	45.7	66.4	78.9	89	115
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	255	280	318	378	490
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	254	281	271	265	316
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	587	631	672	742	1,513
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	90	112	104	94.9	225
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	206	229	226	213	873
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	381	402	446	529	639
Total Liabilities & Shareholders' Equity	587	631	672	742	1,513
Total Common Shares Outstanding